Advertisement
Screener

QUESTCOR PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases

QUESTCOR PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases

QUESTCOR PHARMACEUTICALS INC reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $167.05 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-10-30.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2013-10-30

  • QUESTCOR PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2013-09-30 was $136.66M.
  • QUESTCOR PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2013-06-30 was $0.00.
  • QUESTCOR PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2013-03-31 was $30.38M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month
2013-09-30$136.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$136.66M
derived: sum of 2 quarters · filed 2013-10-30
$167.05M
10-Q · filed 2013-10-30
2013-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
$30.38M
10-Q · filed 2013-07-31
2013-03-31$30.38M
10-Q · filed 2013-05-02